The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / The ACR Responds to CVS Caremark Prior Authorization Changes

The ACR Responds to CVS Caremark Prior Authorization Changes

August 20, 2021 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

On July 1, CVS Caremark updated its prior authorization forms for many biologic drugs. These changes have resulted in an increase to the already overwhelming paperwork burden rheumatology practices face.

You Might Also Like
  • Reminder: How to Handle Part D Prior Authorization Requests
  • UnitedHealthcare Retires Fax Numbers Used for Prior Authorization Requests
  • ACR Introduces Prior Authorization & Step Therapy Resolutions at AMA Meeting
Explore This Issue
September 2021
Also By This Author
  • Join the ACR COVID-19 Clinical Guidance Town Hall: May 6

The ACR sent a letter to CVS Caremark detailing specific concerns about the prior authorization changes and their impact on rheumatology practices and patients’ timely access to treatment and was able to follow up with a direct phone meeting. Chief among the ACR’s concerns are new criteria regarding the evaluation of treatment efficacy for continuation of therapy requests. CVS Caremark leaders have acknowledged these concerns and committed to revising the forms for a more streamlined and user-friendly process.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

ACR will continue to monitor this issue to ensure it is appropriately resolved. We encourage members to contact [email protected] with any questions or concerns.

Filed Under: Billing/Coding, Legislation & Advocacy Tagged With: insurance advocacy, prior authorizationIssue: September 2021

You Might Also Like:
  • Reminder: How to Handle Part D Prior Authorization Requests
  • UnitedHealthcare Retires Fax Numbers Used for Prior Authorization Requests
  • ACR Introduces Prior Authorization & Step Therapy Resolutions at AMA Meeting
  • Reminder: How to Handle Part D Prior Authorization Requests

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)